Literature DB >> 5279330

Management of chronic myeloid leukemia: a five-year survey with a comparison of oral busulfan and splenic irradiation.

M P Gollerkeri, G B Shah.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5279330     DOI: 10.1002/1097-0142(197103)27:3<596::aid-cncr2820270313>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  2 in total

1.  Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2b.

Authors:  N Niederle; O Kloke; D May; R Becher; R Osieka; C G Schmidt
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

2.  Foetal liver infusion in a chronic myeloid leukemia patient with busulphan toxicity.

Authors:  S Sharma; V Kochupillai; H P Pati
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.